Current situation in the development of a preventive HIV vaccine
- 6 January 2009
- journal article
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 23, 15-24
- https://doi.org/10.1016/s0213-005x(05)75157-0
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- CTL ontogeny and viral escape: implications for HIV-1 vaccine designTrends in Immunology, 2004
- HIV Vaccine Trial JustifiedScience, 2004
- HIV-tailored to fitDrug Discovery Today, 2004
- A Sound Rationale Needed for Phase III HIV-1 Vaccine TrialsScience, 2004
- Genomewide Conserved Epitope Profiles of HIV-1 Predicted by Biophysical Properties of MHC Binding PeptidesJournal of Computational Biology, 2004
- Antibody neutralization and escape by HIV-1Nature, 2003
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Short Communication: Unique HIV Type 1 V3 Region Sequences Derived from Six Different Regions of Brain: Region-Specific Evolution within Host-Determined QuasispeciesAIDS Research and Human Retroviruses, 1998
- Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and RecipientsScience, 1995